Arcutis Biotherapeutics, Inc. (ARQT)
26.73
+0.68
(+2.61%)
USD |
NASDAQ |
Jan 14, 16:00
26.93
+0.20
(+0.75%)
Pre-Market: 09:20
Arcutis Biotherapeutics SG&A Expense (TTM): 253.18M for Sept. 30, 2025
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| CorMedix, Inc. | 75.56M |
| ADMA Biologics, Inc. | 96.37M |
| ANI Pharmaceuticals, Inc. | 304.67M |
| Editas Medicine, Inc. | 54.90M |
| Amicus Therapeutics, Inc. | 353.07M |